YPSOMED HLDG SF 14,15/ CH0019396990 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 4.64 bill.EUR | - | - |
GlobeNewswire
12:30 PM
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
GlobeNewswire
12:00 PM
KE Holdings Inc. to Report First Quarter 2024 Financial Results on May 23, 2024 Eastern Time
GlobeNewswire
12:00 PM
Bilibili Inc. to Report First Quarter 2024 Financial Results on Thursday, May 23, 2024
GlobeNewswire
12:00 PM
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologie...
GlobeNewswire
12:00 PM
Tessera Therapeutics Presents New Preclinical Data Highlighting Advancements Across Its Portfolio Pr...
GlobeNewswire
12:00 PM
Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT
GlobeNewswire
11:58 AM
IOTSWC unveils the latest disruptive technologies for industrial transformation
GlobeNewswire
11:00 AM
BitFuFu Inc. to Report First Quarter 2024 Unaudited Financial Results on May 20, 2024